Summary
Fetal substantia nigra (SN) cells were transplanted into the caudate nucleus (CN) of four vervet monkeys (Cercopithecus aethiops sabaeus) that had been treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MPTP treatment appears to produce a syndrome similar to that observed in patients with idiopathic Parkinson's disease. Normal and parkinsonian behaviors were quantitated by trained observers 5 days/week. Twenty-eight behaviors based on previous factor analyses were individually scored and rated. Parkinsonian signs included freezing, head and limb tremor, difficulty in eating, delayed initiation of movement, poverty of movement, tremor that stopped with intention, decreased response to threats, and lying immobile in the cage. These signs were combined to give an overall rating of parkinsonism. A summary measure of ‘normal’ healthy behavior was also examined, including such behaviors as yawning, scratching, self-grooming, shifting, and eating. Overall ratings of parkinsonism increased and those of healthy behavior decreased after MPTP. In the 4 monkeys grafted with fetal SN cells into the CN, behavior returned to pre-treatment levels by the time of sacrifice (2, 5, or 7.5 months after grafting). Three control subjects were transplanted with either SN cells into an inappropriate brain site (cortex) or inappropriate, non-dopaminergic, cells (cerebellar) into the CN. Subjects were also compared with three control animals that did not receive MPTP but received cryopreserved or fresh SN and other cells into the CN. Only MPTP-treated subjects that received SN cells into the CN showed evidence of a reversal of the MPTP syndrome after transplantation. In addition, grafting in animals that were not MPTP-treated did not appear to affect behavior. This paper reports the specific behavioral effects of severe MPTP toxicity that were or were not reversed after transplantation and suggests that only fetal SN cells grafted into the CN may be able to reverse behavioral deficits in MPTP-treated monkeys.
Similar content being viewed by others
References
Altman J (1974) Observational study of behavior: sampling methods. Behavior 49: 222–267
Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39: 7–16
Baulu J, Redmond DE Jr (1978) Some sampling considerations in the quantitation of monkey behavior under field and captive conditions. Primates 19: 391–399
Benecke R, Rothwell JC, Dick JPR, Day BL, Marsden CD (1987) Disturbance of sequential movements in patients with Parkinson's disease. Brain 110: 361–379
Björklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177: 555–560
Björklund A, Stenevi U (1984) Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. Ann Rev Neurosci 7: 279–308
Björklund A, Stenevi U, Dunnett SB, Iversen SD (1981) Functional reactivation of the deafferented neostriatum by nigral transplants. Nature (Lond) 289: 497–499
Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurobiology 80: 4546–4550
Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ (1985) The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New England J Med 312: 1418–1421
Chiueh CC, Markey SP, Burns RS, Johannessen JN, Jacobowitz DM, Kopin IJ (1984) Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat guinea pig and monkey. Psychopharmacol Bull 20: 548–553
Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ (1985) III Primate model of Parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-1–4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci 36: 213–218
Collier TJ, Redmond, DE Jr, Sladek CD, Gallagher MJ, Roth RH, Sladek JR Jr (1987a) Intracerebral grafting and culture of cryopreserved primate dopamine neurons. Brain Res 436: 363–366
Collier TJ, Redmond, DE Jr, Roth RH, Sladek JR Jr (1987b) Neural cell replacement in a primate model of parkinsonism. Banbury report 27: Cold Spring Harbor Laboratory
Degryse A-D, Colpaert FC (1986) Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)]. Brain Res Bull 16: 561–571
Diamond A (1989) Frontal lobe involvement in cognitive changes during the first year of life. In: Gibson K, Konner M, Petersen A (eds) Brain and behavioral development. Aldine Press, NY
Di Paolo T, Bedard P, Daigle M, Boucher R (1986) Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys. Brain Res 379: 286–293
Doudet D, Gross C, Lebrun-Grandie P, Bioulac B (1985) MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study. Brain Res 335: 194–199
Doudet D, Gross C, Lebrun-Grandie P, Bioulac B (1986) Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkeys: mechanographic and electromyographic data. Electromyogr Clin Neurophysiol 26: 11–727
Eidelberg E, Brooks BA, Morgan WW, Walden JG, Kokemoor RH (1986) Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydroprydine model of parkinsonism in monkeys. Neuroscience 18: 817–822
Elsworth JD, Deutch AY, Redmond DE Jr, Sladek JR Jr, Roth RH (1987a) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridme (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res 415: 293–299
Elsworth JD, Deutch AY, Redmond DE Jr, Sladek JR Jr, Roth RH (1987b) Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. Life Sci 40: 193–202
Elsworth JD, Deutch AY, Redmond DE Jr, Taylor JR, Sladek JR Jr, Roth RH (1989) Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primates: biochemical changes in striatal regions. Neuroscience 33: 323–331
Elsworth JD, Redmond DE Jr, Sladek JR Jr, Deutch AY, Collier TJ, Roth RH (1990) Reversal of MPTP induced parkinsonism in primates by fetal dopamine cell transplants. In: AJ Franks, JW Ironside, RHS Mindham, RJ Smith, EGS Spokes, W Winlow (eds) Function and dysfunction of the basal ganglia. University Press, Manchester, pp 161–181
Gash D, Sladek JR, Sladek CD, (1980) Functional development of grafted vasopression neurons. Science 201: 1367–1369
Jenner P, Marsden CD (1986) The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. J Neural Transmiss Suppl XX: 11–39
Kitt CA, Cork LC, Eidelberg F, Joh TH, Price DL (1986) Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in the monkey. Neuroscience 17: 1089–1103
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980
Langston JW, Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292: 390–394
Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106: 257–270
Lockman JL (1984) The development of detour ability during infancy. Child Dev 55: 482–491
Loranger AW, Goodell H, McDownell FH, Lee JE, Sweet RD (1972) Intellectual impairment in Parkinson's syndrome. Brain 95: 405–412
Lund RA, Hauschka SD (1976) Transplanted neural tissue develops connections with host rat brain. Science 193: 582–584
Mitchel IJ, Cross AJ, Sambrook MA, Crossman AR (1986) N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism. J Neural Transm Suppl XX: 41–46
Nomoto M, Jenner P, Marsden CD (1986) Alterations in motor behavior produced by the isomers of 3-PPP in the MPTP-treated marmoset. Europ J Pharmacol 121: 123–128
Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ (1979) Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science 204: 643–647
Redmond DE Jr, Sladek JR Jr, Deutch AY, Haber SN (1986) Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (8490) 1125–1127
Redmond DE Jr, Sladek JR Jr, Roth RH (1987) Transplanted cells: a future treatment for Parkinson's disease? Neuro Consult 4(2): 1–8
Redmond, DE Jr, Sladek JR Jr, Roth RH, Collier TJ, Elsworth JD, Taylor, JR, Deutch AY, Haber SN (1988) Transplanted fetal dopamine neurons: a future treatment for Parkinson's disease? In: Sandler M, Dahlström A, Belmaker RH (eds) Progress in catecholamine research, Part B. Central aspects. Alan Liss Inc, NY, pp 117–123
Reitan RM, Boll TJ (1971) Intellectual and cognitive functions in Parkinson's disease. J Consult Clin Psychol 37: 364–369
Schneider JS, Yuwiler A, Markham CH (1987) Selective loss of subpopulations of ventral mesencephalic dopamine neurons in the monkey following exposure to MPTP. Brain Res 411: 144–150
Schneider JS, Unguez, G, Yuwiler A, Berg SC, Markham CH (1988) Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Brain 111: 1265–1285
Schultz W, Studer A, Jonsson G, Sundstrom E, Mefford I (1985) Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neurosci Lett 59: 225–232
Sladek JR Jr, Hoffman G (1983) Simultaneous analysis of monoaminergic and peptidergic neurons. In: Barker J, McKelvy J (eds) Current methods in cellular neurobiology. Wiley and Sons, NY, pp 203–217
Sladek JR Jr, Collier TJ, Haber SN, Roth RH, Redmond DE Jr (1986) Survival and growth for fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 17: 809–818
Sladek JR Jr, Redmond DE Jr, Collier TJ, Haber SN, Elsworth JD, Deutch AY, Roth RH (1987a) Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism. Progr Brain Res 71: 309–322
Sladek JR Jr, Collier TJ, Haber SN, Deutch AY, Elsworth JD, Roth RH, Redmond DE Jr (1987b) Reversal of parkinsonism by fetal nerve cell transplants in primate brain. Ann NY Acad Sci 495: 641–657
Sladek JR Jr, Redmond DE Jr, Collier TJ, Blount JP, Elsworth JD, Taylor JR, Roth RH (1988a) Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydrapyridine-induced parkinsonism in monkeys. Progr Brain Res 78: 497–506
Sladek JR Jr, Redmond DE Jr, Roth RH (1988b) Transplantation of fetal neurons in primates. Clin Res 36: 200–204
Stern Y, Langston W (1985) Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35: 1506–1509
Stern Y, Mayeux R, Rosen J, Ilson J (1983) Perceptual motor dysfunction in parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatr 46: 145–151
Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr (1990a) Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113: 617–637
Taylor JR, Roth RH, Sladek JR Jr, Redmond DE Jr (1990b) Cognitive and motor deficits in the performance of an object retrieval task with barrier/detour in monkeys treated with MPTP: long-term performance and effect of transparency of the barrier. Behav Neurosci 104: 564–576
Taylor JR, Elsworth JD, Roth RH, Collier TJ, Sladek JR Jr, Redmond DE Jr (1990c) Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Progr Brain Res 82 (in press)
US Public Health Service (1985) Guide for the care and use of animals US Government Printing Office, Washington DC
Weingartner H, Burns S, Diebel R, LeWitt PA (1984) Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiat Res 11: 223–235
Winer BJ (1974) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, J.R., Elsworth, J.D., Roth, R.H. et al. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp Brain Res 85, 335–348 (1991). https://doi.org/10.1007/BF00229411
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00229411